For the treatment of hypoglycemia, glucagon may be underused in outpatient settings, researchers argued. In a nationwide analysis, most states only permit paramedics to carry and administer glucagon ...
Students have a variety of medical needs to be addressed in school and New York law provides procedures for managing those needs. This includes medication administration to students. One such ...
Glucagon is underused for treating severe hypoglycemia in both emergency and outpatient settings, new research suggests. Findings from an analysis of data on glucagon administration by emergency ...
Please provide your email address to receive an email when new articles are posted on . Schools need someone who is trained in how to administer insulin and how to look for reactions — both ...
Credit: Thinkstock. Noting that there are 198,200 providers of basic emergency medicine compared with 61,121 paramedics (who are the only members of EMS who carry and administer glucagon), 3 out of 4 ...
The US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the treatment of severe hypoglycemia for patients aged 4 years or ...
The YMCA of Metro Chicago has agreed to train its employees to administer the emergency medicine glucagon to diabetics who request it as part of a settlement to a discrimination complaint, the U.S.
Xeris Pharmaceuticals, Inc. (“Xeris”) recently announced successful completion of both adult and pediatric clinical studies for its glucagon rescue pen. According to Xeris’ President and CEO Paul ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Insulin-induced hypoglycemia was ...
(BPT) – Jolting awake in the middle of the night to the screeching sound of your child’s low blood sugar alert alarm. Feeling the onset of blurry vision during a road trip with the closest exit miles ...
The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an ...